Lakshmi Amaravadi
Head of Oncology Bioanalytical Strategy Team, Clinical Pharmacology & Safety Sciences AstraZeneca
Lakshmi Amaravadi, PhD, is Head of Oncology Bioanalytical Strategy at AstraZeneca, overseeing PK, PD, and immunogenicity strategies supporting preclinical and clinical programs across multiple modalities. She has more than 30 years of drug-development experience across oncology, neurology, autoimmune, metabolic, and rare diseases. During her career at Biogen, Sanofi, Shire, and Boston Pharma, she supported numerous successful INDs, BLAs, NDAs, and registrations. An active AAPS scientific-community leader and former board member, Lakshmi is passionate about innovative translational approaches and mentoring the next generation of scientists. She holds a Ph.D. in Cell, Molecular and Developmental Biology.
Seminars
- Developing stage-appropriate bioanalytical strategies for conventional and dual-payload ADCs
- Using clinical case studies to inform ADC immunogenicity assessment across indications and development stages
- Applying science- and risk-based approaches to dual-payload ADCs and combinations